International Flavors & Fragrances Inc. (NYSE:IFF) Shares Sold by Metis Global Partners LLC

Metis Global Partners LLC lowered its holdings in International Flavors & Fragrances Inc. (NYSE:IFF) by 6.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,437 shares of the specialty chemicals company’s stock after selling 830 shares during the period. Metis Global Partners LLC’s holdings in International Flavors & Fragrances were worth $1,200,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in IFF. Empowered Funds LLC grew its stake in shares of International Flavors & Fragrances by 29.0% in the 1st quarter. Empowered Funds LLC now owns 3,453 shares of the specialty chemicals company’s stock worth $297,000 after purchasing an additional 776 shares during the last quarter. Sei Investments Co. grew its stake in shares of International Flavors & Fragrances by 55.4% in the 1st quarter. Sei Investments Co. now owns 101,015 shares of the specialty chemicals company’s stock worth $8,686,000 after purchasing an additional 36,026 shares during the last quarter. Dorsey & Whitney Trust CO LLC acquired a new position in shares of International Flavors & Fragrances in the 1st quarter worth approximately $239,000. Intech Investment Management LLC grew its stake in shares of International Flavors & Fragrances by 24.2% in the 1st quarter. Intech Investment Management LLC now owns 11,434 shares of the specialty chemicals company’s stock worth $983,000 after purchasing an additional 2,228 shares during the last quarter. Finally, Ontario Teachers Pension Plan Board acquired a new position in shares of International Flavors & Fragrances in the 1st quarter worth approximately $952,000. Institutional investors and hedge funds own 96.02% of the company’s stock.

Insider Transactions at International Flavors & Fragrances

In related news, insider Yuvraj Arora sold 5,000 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $91.75, for a total transaction of $458,750.00. Following the transaction, the insider now owns 3,238 shares of the company’s stock, valued at approximately $297,086.50. The trade was a 60.69 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently weighed in on IFF shares. Stifel Nicolaus lifted their target price on shares of International Flavors & Fragrances from $115.00 to $121.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Morgan Stanley raised shares of International Flavors & Fragrances from an “equal weight” rating to an “overweight” rating and dropped their target price for the stock from $111.00 to $110.00 in a research report on Tuesday, November 12th. JPMorgan Chase & Co. dropped their target price on shares of International Flavors & Fragrances from $110.00 to $107.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Barclays lifted their target price on shares of International Flavors & Fragrances from $93.00 to $99.00 and gave the stock an “equal weight” rating in a research report on Friday, October 11th. Finally, Mizuho raised shares of International Flavors & Fragrances from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $109.00 to $120.00 in a research report on Tuesday, September 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $109.27.

International Flavors & Fragrances Price Performance

NYSE IFF opened at $86.14 on Friday. The company has a quick ratio of 1.93, a current ratio of 2.62 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $22.02 billion, a PE ratio of -9.48, a price-to-earnings-growth ratio of 1.58 and a beta of 1.22. The company has a 50 day moving average price of $100.76 and a two-hundred day moving average price of $98.33. International Flavors & Fragrances Inc. has a 12-month low of $72.89 and a 12-month high of $106.77.

International Flavors & Fragrances (NYSE:IFF) last issued its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $0.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.08 by ($0.46). International Flavors & Fragrances had a positive return on equity of 7.16% and a negative net margin of 20.33%. The firm had revenue of $2.93 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the firm posted $0.89 earnings per share. International Flavors & Fragrances’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, equities analysts predict that International Flavors & Fragrances Inc. will post 4.17 earnings per share for the current fiscal year.

International Flavors & Fragrances Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 8th. Stockholders of record on Friday, December 20th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date of this dividend is Friday, December 20th. International Flavors & Fragrances’s payout ratio is -17.60%.

International Flavors & Fragrances Profile

International Flavors & Fragrances Inc, together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions.